Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jan-24 3:20 PM View:  | Wesson Bruce F/ Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-24 | Option Exercise | 37,500 | -- | -- | 5% 792.05K to 829.55K | |
| 02-Jan-24 3:23 PM View: | Skelly William G Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-24 | Option Exercise | 50,000 | -- | -- | 10% 525.99K to 575.99K | |
| 02-Jan-24 3:20 PM View: | Thangaraj Immanuel Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-24 | Option Exercise | 50,000 | -- | -- | 2% 2.35M to 2.4M | |
| 02-Jan-24 3:23 PM View: | Ross George K Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-24 | Option Exercise | 50,000 | -- | -- | 11% 445.5K to 495.5K | |
| 20-Nov-23 12:08 PM View: | Seiser Robert A VP, Treasurer & Controller | Acura Pharmaceuticals Inc. (ACUR) | 20-Nov-23 | Option Exercise | 40,000 | -- | -- | 10% 398.25K to 438.25K | |
| 20-Nov-23 12:08 PM View: | Jones Robert B President & CEO | Acura Pharmaceuticals Inc. (ACUR) | 20-Nov-23 | Option Exercise | 40,000 | -- | -- | 7% 603.55K to 643.55K | |
| 20-Nov-23 12:07 PM View: | Brzeczko Albert W See Remarks | Acura Pharmaceuticals Inc. (ACUR) | 20-Nov-23 | Option Exercise | 40,000 | -- | -- | 9% 446.0K to 486.0K | |
| 20-Nov-23 12:07 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 20-Nov-23 | Option Exercise | 40,000 | -- | -- | 8% 505.43K to 545.43K | |
| 05-Jan-23 4:09 PM View: | Jones Robert B President & CEO | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 50,000 | -- | -- | 9% 553.55K to 603.55K | |
| 05-Jan-23 4:06 PM View: | Ross George K Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 66,666 | -- | -- | 18% 378.84K to 445.5K | |
| 05-Jan-23 4:08 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 40,000 | -- | -- | 9% 465.43K to 505.43K | |
| 05-Jan-23 4:08 PM View: | Brzeczko Albert W See Remark | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 34,000 | -- | -- | 8% 412.0K to 446.0K | |
| 05-Jan-23 4:05 PM View: | Skelly William G Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 66,666 | -- | -- | 15% 459.32K to 525.99K | |
| 05-Jan-23 4:06 PM View: | Wesson Bruce F/ Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 66,666 | -- | -- | 9% 725.38K to 792.05K | |
| 05-Jan-23 4:06 PM View: | Thangaraj Immanuel Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 66,666 | -- | -- | 3% 2.29M to 2.35M | |
| 05-Jan-23 4:09 PM View: | Seiser Robert A VP, Treasurer & Controller | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-23 | Option Exercise | 20,000 | -- | -- | 5% 378.25K to 398.25K | |
| 05-Aug-22 4:16 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 03-Aug-22 | Option Exercise | 49,333 | -- | -- | 12% 416.1K to 465.43K | |
| 05-Aug-22 4:17 PM View: | Seiser Robert A VP, Controller & Treasurer | Acura Pharmaceuticals Inc. (ACUR) | 03-Aug-22 | Option Exercise | 24,666 | -- | -- | 7% 353.59K to 378.25K | |
| 05-Aug-22 4:17 PM View: | Jones Robert B President & CEO | Acura Pharmaceuticals Inc. (ACUR) | 03-Aug-22 | Option Exercise | 63,666 | -- | -- | 13% 489.89K to 553.55K | |
| 05-Aug-22 4:17 PM View: | Brzeczko Albert W VP, Pharma Sciences - APT | Acura Pharmaceuticals Inc. (ACUR) | 03-Aug-22 | Option Exercise | 43,333 | -- | -- | 12% 368.67K to 412.0K | |
| 11-Jan-22 4:10 PM View: | Wesson Bruce F/ Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-22 | Option Exercise | 66,666 | -- | -- | 10% 658.72K to 725.38K | |
| 10-Jan-22 4:11 PM View: | Ross George K Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-22 | Option Exercise | 66,666 | -- | -- | 21% 312.17K to 378.84K | |
| 05-Jan-22 4:15 PM View: | Skelly William G Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-22 | Option Exercise | 66,666 | -- | -- | 17% 392.66K to 459.32K | |
| 12-Jan-22 4:10 PM View: | Thangaraj Immanuel Director | Acura Pharmaceuticals Inc. (ACUR) | 03-Jan-22 | Option Exercise | 66,666 | -- | -- | 3% 2.22M to 2.29M | |
| 28-Jun-21 11:00 AM View: | Abuse Deterrent Pharma, LLC 10% Owner | Acura Pharmaceuticals Inc. (ACUR) | 09-Jun-21 | Conversion | 42,984,400 | $0.16 | $6,877,500.00 | 100% 0 to 42.98M | |
| 28-Jun-21 10:53 AM View: | Schutte John 10% Owner | Acura Pharmaceuticals Inc. (ACUR) | 09-Jun-21 | Conversion Duplicate | 42,984,400 | $0.16 | $6,877,500.00 | 482% 8.91M to 51.9M | |
| 26-Feb-21 4:11 PM View: | Seiser Robert A VP, Treasurer & Controller | Acura Pharmaceuticals Inc. (ACUR) | 24-Feb-21 | Payment of Exercise | 7,550 | $0.40 | $3,020.00 | (2%) 361.14K to 353.59K | |
| 26-Feb-21 4:11 PM View: | Seiser Robert A VP, Treasurer & Controller | Acura Pharmaceuticals Inc. (ACUR) | 24-Feb-21 | Option Exercise | 20,000 | $0.15 | $3,020.00 | 6% 341.14K to 361.14K | |
| 26-Feb-21 4:11 PM View: | Emigh James F VP, Corporate Development | Acura Pharmaceuticals Inc. (ACUR) | 24-Feb-21 | Payment of Exercise | 7,550 | $0.40 | $3,020.00 | (2%) 481.59K to 474.04K | |
| 26-Feb-21 4:11 PM View: | Emigh James F VP, Corporate Development | Acura Pharmaceuticals Inc. (ACUR) | 24-Feb-21 | Option Exercise | 20,000 | $0.15 | $3,020.00 | 4% 461.59K to 481.59K | |
| 26-Feb-21 4:10 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 24-Feb-21 | Payment of Exercise | 15,100 | $0.40 | $6,040.00 | (4%) 431.2K to 416.1K | |
| 26-Feb-21 4:10 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 24-Feb-21 | Option Exercise | 40,000 | $0.15 | $6,040.00 | 10% 391.2K to 431.2K | |
| 06-Jan-21 4:11 PM View: | Skelly William G Director | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 54,790 | -- | -- | 16% 337.87K to 392.66K | |
| 06-Jan-21 4:10 PM View: | Emigh James F VP, Corporate Development | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Payment of Exercise | 7,402 | $0.21 | $1,554.42 | (2%) 468.99K to 461.59K | |
| 06-Jan-21 4:10 PM View: | Emigh James F VP, Corporate Development | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 24,667 | -- | -- | 6% 444.33K to 468.99K | |
| 12-Jan-21 4:10 PM View: | Thangaraj Immanuel Director | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 54,790 | -- | -- | 3% 2.17M to 2.22M | |
| 06-Jan-21 4:10 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Payment of Exercise | 19,514 | $0.21 | $4,097.94 | (5%) 410.71K to 391.2K | |
| 06-Jan-21 4:10 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 49,334 | -- | -- | 14% 361.38K to 410.71K | |
| 06-Jan-21 4:11 PM View: | Jones Robert B President & CEO | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 63,667 | -- | -- | 15% 426.22K to 489.89K | |
| 06-Jan-21 4:10 PM View: | Brzeczko Albert W VP, Pharmaceutical Sciences | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 43,334 | -- | -- | 13% 325.33K to 368.67K | |
| 06-Jan-21 4:12 PM View: | Wesson Bruce F/ Director | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 54,790 | -- | -- | 9% 603.93K to 658.72K | |
| 06-Jan-21 4:12 PM View: | Ross George K Director | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 54,790 | -- | -- | 21% 257.38K to 312.17K | |
| 06-Jan-21 4:11 PM View: | Seiser Robert A VP, Treasurer & Controller | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Payment of Exercise | 10,686 | $0.21 | $2,244.06 | (3%) 351.82K to 341.14K | |
| 06-Jan-21 4:11 PM View: | Seiser Robert A VP, Treasurer & Controller | Acura Pharmaceuticals Inc. (ACUR) | 04-Jan-21 | Option Exercise | 24,667 | -- | -- | 8% 327.16K to 351.82K | |
| 06-Jan-20 4:37 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-20 | Payment of Exercise | 3,090 | $0.23 | $710.70 | (< 1%) 364.47K to 361.38K | |
| 06-Jan-20 4:37 PM View: | Clemens Peter A Senior VP & CFO | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-20 | Option Exercise | 9,334 | -- | -- | 3% 355.13K to 364.47K | |
| 06-Jan-20 4:39 PM View: | Jones Robert B President & CEO | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-20 | Option Exercise | 13,667 | -- | -- | 3% 412.56K to 426.22K | |
| 06-Jan-20 4:35 PM View: | Wesson Bruce F/ Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-20 | Option Exercise | 83,333 | -- | -- | 16% 520.59K to 603.93K | |
| 06-Jan-20 4:36 PM View: | Ross George K Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-20 | Payment of Exercise | 3,624 | $0.23 | $833.52 | (1%) 261.0K to 257.38K | |
| 06-Jan-20 4:36 PM View: | Ross George K Director | Acura Pharmaceuticals Inc. (ACUR) | 02-Jan-20 | Option Exercise | 50,000 | -- | -- | 24% 211.0K to 261.0K |
